Common Contracts
4 similar Securities Purchase Agreement contracts by Xenomics Inc, Callisto Pharmaceuticals Inc, Fermavir Pharmaceuticals, Inc.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 16th, 2007 • Fermavir Pharmaceuticals, Inc. • Pharmaceutical preparations
This Securities Purchase Agreement (this “Agreement”) is made as of January 10, 2007 between FermaVir Pharmaceuticals, Inc., a Florida corporation (the “Company”), and the investors listed on Exhibit A hereto, each of which is herein referred to as an “Investor” and collectively, the “Investors”.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 28th, 2006 • Xenomics Inc • Biological products, (no disgnostic substances)
This Securities Purchase Agreement (this “Agreement”) is made as of December 21, 2006 between Xenomics, Inc., a Florida corporation (the “Company”), and the investors listed on Exhibit A hereto, each of which is herein referred to as an “Investor” and collectively, the “Investors”.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 26th, 2006 • Xenomics Inc • Biological products, (no disgnostic substances)
This Securities Purchase Agreement (this “Agreement”) is made as of ____, 2006 between Xenomics, Inc., a Florida corporation (the “Company”), and the investors listed on Exhibit A hereto, each of which is herein referred to as an “Investor” and collectively, the “Investors”.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 9th, 2006 • Callisto Pharmaceuticals Inc • Pharmaceutical preparations
This Securities Purchase Agreement (this “Agreement”) is made as of February 3, 2006 between Callisto Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investors listed on Exhibit A hereto, each of which is herein referred to as an “Investor” and collectively, the “Investors”.
